Skip to content
2000
Volume 7, Issue 3
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Obesity and the metabolic syndrome are becoming one of the biggest health challenges of the 21st century. Cholesterol metabolism is significantly altered in both obesity and metabolic syndrome in that cholesterol synthesis is increased and absorption reduced and this has important implications for the treatment of lipid disorders in both obesity and the metabolic syndrome. In the present review we discuss these changes in detail especially in the context of a more standardized approach for cholesterol reduction like the TARGET LDL trial. Customized care is topical in lipidology as we strive to achieve LDL cholesterol and non-HDL cholesterol targets in every patient.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/187153007781662567
2007-09-01
2025-10-16
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/187153007781662567
Loading

  • Article Type:
    Research Article
Keyword(s): cholestanol; Cholesterol; diabetes; ezetimibe; metabolic syndrome; obesity; statins
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test